Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 21, 2004 FBO #0999
SOURCES SOUGHT

65 -- Immounassay Test Reagent for LSD Metabolite, 2-oxo-3-hydroxy-LSD

Notice Date
8/19/2004
 
Notice Type
Sources Sought
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
Department of the Navy, Bureau of Medicine and Surgery, NMLC, 1681 Nelson St, FT Detrick, MD, 21702-9203
 
ZIP Code
21702-9203
 
Solicitation Number
Reference-Number-oxo-lsd
 
Response Due
9/2/2004
 
Archive Date
9/17/2004
 
Point of Contact
Ralph Payne, Contracting Officer, Phone 301-619-3026, Fax 301-619-2925,
 
E-Mail Address
repayne@nmlc.med.navy.mil
 
Description
The Naval Medical Logistics Command has a requirement to identify potential sources to provide immunoassay test reagent specific for the lysergic acid diethylamide (LSD) metabolite, 2-oxo-3-hydroxy-LSD. The reagent shall be for the initial (screen) testing for the LSD metabolite 2-oxo-3-hydroxy-LSD in urine from LSD abuse. The reagent must provide performance characteristics of sensitivity and specificity for detection of the LSD metabolite 2-oxo-3-hydroxy-LSD in urine at a desired target concentration of approximately 1.0 ng/ml. The reagent must be compatible for use with the Roche-Hitachi D-P Modular automated drug screening equipment, and must be applicable without modification of the equipment. The reagent must be compatible with the optimal throughput of this system and must not interfere with the optimum performance of other immunoassay procedures in the military laboratories. Be advised that this is not a request for the submission of offers or proposals; no contract award will be made as a result of this notice. Responses should include relative information for a drug screening reagent specific for the LSD metabolite, 2-oxo-3-hydroxy-LSD. Immunoassay kits are medical devices that require FDA approval to market. Responses should indicate FDA compliance or the estimated lead time required to obtain FDA approval for an immunoassay kit specific for the LSD metabolite, 2-oxo-3-hydroxy-LSD. Submit responses no later than Thursday September 2nd to Naval Medical Logistics Command, Code 02 / Ralph Payne, 1681 Nelson Street, Fort Detrick, MD 21702-9203. Responses may also be emailed to repayne@nmlc.med.navy.mil.
 
Record
SN00647673-W 20040821/040819212718 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.